Management of Recurrent Pregnancy Loss: A Comprehensive Approach
Recurrent pregnancy loss (RPL) requires a systematic evaluation of potential causes and evidence-based management strategies to improve outcomes, with up to 75% of cases remaining unexplained despite thorough investigation. 1
Definition and Epidemiology
- RPL is commonly defined as three or more consecutive pregnancy losses before 24 weeks of gestation, affecting approximately 1-5% of couples attempting pregnancy 1, 2
- The inconsistency in definitions (two versus three losses) and inclusion criteria (types of pregnancy and gestational age) makes true incidence difficult to determine 1
Evaluation of Potential Causes
Genetic Factors
- Parental chromosomal abnormalities should be evaluated in couples with RPL 2
- Genetic testing of products of conception can provide an explanation for the miscarriage and valuable prognostic information 3
- Some patients with recurrent complete hydatidiform moles may have mutations in NLRP7 and KHDC3L genes 4
Anatomical Factors
- Uterine cavity abnormalities can interfere with implantation and cause recurrent pregnancy loss 5
- Müllerian anomalies, intrauterine synechiae, and cervical incompetence should be evaluated 5
- Imaging studies such as transvaginal ultrasound (TVUS), sonohysterography (SIS), or hysterosalpingography (HSG) can help identify structural abnormalities 5
Endocrine Factors
- Diminished ovarian reserve may be associated with increased miscarriage risk, particularly with severely reduced AMH levels 4
- Screening for thyroid disorders should be considered, with levothyroxine indicated for overt hypothyroidism 2
- Polycystic ovary syndrome (PCOS) is associated with higher rates of pregnancy loss and should be evaluated 5
Thrombophilias
- Certain thrombophilias may increase risk of pregnancy loss 4
- Women with homozygous factor V Leiden or prothrombin 20210A mutation with positive family history for venous thromboembolism (VTE) should receive antepartum prophylaxis with prophylactic or intermediate-dose low molecular weight heparin (LMWH) 4
- Antiphospholipid syndrome (APS) is a well-established cause of RPL and should be screened for in all cases 2, 6
Management Strategies
Evidence-Based Treatments
- Low-dose aspirin plus heparin is indicated for the treatment of antiphospholipid syndrome 2
- Levothyroxine is recommended for overt hypothyroidism 2
- Genetic counseling is required in cases of abnormal parental karyotype 2
Treatments Not Recommended
- There is no evidence supporting the use of low-molecular-weight heparin for the sole indication of prevention of recurrent fetal growth restriction 5
- Sildenafil and activity restriction are not recommended for in utero treatment of fetal growth restriction 5
- Immunotherapy and anticoagulants are not recommended for unexplained RPL 2
Lifestyle Modifications
- Regular physical activity within guidelines is unlikely to increase the risk of pregnancy loss in women with RPL 5, 7
- Exercise may actually benefit factors that increase miscarriage risk, such as insulin resistance and obesity 7
- A recent meta-analysis demonstrated no increased odds of miscarriage or perinatal mortality in otherwise healthy pregnant women who exercised compared with those who did not 7
Male Factor Evaluation
- In couples with recurrent pregnancy losses (two or more), clinicians should evaluate the male partner 5
- Male partners should be evaluated by reproductive experts, with consideration for karyotype and sperm DNA fragmentation testing 5
- An increasing number of studies have linked recurrent pregnancy loss with abnormal male partner karyotype and elevated levels of sperm DNA fragmentation 5
Prognosis and Support
- Despite the cause of RPL, patients should be reassured that the prognosis for live birth with an evidence-based approach is excellent for most patients 3
- Psychological support is essential as RPL can have significant impacts on mental health and well-being 1
Management Algorithm for Current Pregnancy with History of RPL
- Confirm viable intrauterine pregnancy with early ultrasound
- For patients with APS: initiate low-dose aspirin plus heparin 2
- For patients with thyroid disorders: optimize thyroid function with appropriate medication 2
- For patients with history of cervical insufficiency: consider cerclage based on previous reproductive history 2
- Regular prenatal visits with serial ultrasound monitoring
- Provide emotional support and counseling throughout pregnancy 1
The management of RPL remains challenging, particularly for unexplained cases. A systematic approach to diagnosis and evidence-based treatments offer the best chance for successful outcomes.